|
| Biofilm-producing strains | Quercetin/quercetin conjugate | Effect |
|
| Bacillus subtilis strain FB17 [41] | Quercetin | Quercetin diminished biofilm formation |
|
| Enterococcus faecalis MTCC 2729 [36] | Quercetin | At submic concentrations, quercetin inhibits biofilm formation. Compared with the control group, 10 and 9 proteins were overexpressed and effective after quercetin treatment |
|
| A vancomycin-resistant Enterococcus Faecalis [37] | Quercetin–pivaloxymethyl conjugate (Q-POM) | Q-POM efficiently hampered biofilm formation in a dose-dependent manner |
|
| Staphylococcus aureus ATCC 6538 [39] | Quercetin | Quercetin not only abolished the biofilm forming and hemolytic S. aura but also suppresses the expression of adhesion-related, quorum sensing, and virus-regulatory genes |
|
| Staphylococcus aureus ATCC 25923 [39] | Quercetin | Quercetin not only abolished the biofilm forming and hemolytic S. aura but also suppresses the expression of adhesion-related, quorum sensing, and virus-regulatory genes |
|
| A clinical isolate of Staphylococcus aureus [42] | Quercetin-AgNP hybrid | Quercetin-AgNP hybrid significantly reduced the formation of biofilms and the production of extracellular polymers |
|
| MSSA ATCC 29213, MRSA ATCC 33591, and clinical isolates of Staphylococcus aureus [43] | Quercetin | Quercetin (at MIC and sub-MICs) inhibited around 50% of biofilm establishment |
|
| Streptococcus mutans strain Ingbritt [44] | Quercetin-doped adhesive groups | Compared with the control group, the binder group doped with quercetin showed antibacterial activity, acceptable biocompatibility, inhibition of matrix metalloproteinases, and an effective bonding interfacial seal |
|
| Clinical isolates of Pseudomonas Aeruginosa [45] | Quercetin | Quercetin basically inhibits biofilm formation and twitching movements |
|
| Proteus mirabilis HI4320 [46] | Quercetin | Quercetin dose dependently increased biofilm establishment |
|
| Streptococcus pneumoniae strain D39 [47] | Quercetin | Quercetin reduced biofilm formation and CFUs in a dose-dependent manner |
|
